📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Humacyte

1.1 - Company Overview

Humacyte Logo

Humacyte

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of bioengineered vascular and anatomical conduit solutions, including the Human Acellular Vessel (HAV) in clinical trials for trauma repair and arteriovenous access; the LUNA200 bioengineering system for producing HAV; and the BioVascular Pancreas in preclinical studies for type 1 diabetes, delivering insulin-producing islets.

Products and services

  • BioVascular Pancreas: A preclinical-stage product engineered for type 1 diabetes treatment by delivering insulin-producing islets
  • Human Acellular Vessel (HAV): A bioengineered vascular conduit in clinical trials that enables trauma repair and arteriovenous access across diverse vascular applications
  • LUNA200™ bioengineering system: A bioengineering platform developed to produce Human Acellular Vessels, aiming to transform medical practices by enabling HAV production

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Humacyte

ACell Logo

ACell

HQ: United States Website
  • Description: Provider of extracellular matrix devices and acellular, resorbable MatriStem/UBM matrices for tissue repair and remodeling in surgical and wound care, including Cytal Wound Matrix, Cytal Burn Matrix, MicroMatrix UBM Particulate, and Gentrix Surgical Matrix.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ACell company profile →
BioD Logics Logo

BioD Logics

HQ: United States Website
  • Description: Provider of novel biologic products derived from placental tissues, engaged in the development and commercialization of biologics and focused on research into the regenerative potential of amnion and other placental tissues; a vertically integrated biotechnology company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioD Logics company profile →
Neuroplast Logo

Neuroplast

HQ: The Netherlands Website
  • Description: Provider of neuro-regenerative personalized medicine, a promising therapy that needs dedicated uniform standards and regulations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neuroplast company profile →
Harbor MedTech Logo

Harbor MedTech

HQ: United States Website
  • Description: Provider of tissue regeneration products for chronic wounds, hernia and joint repair. Offers Architect, a stabilized collagen matrix for various chronic skin wounds; BPMatrix, a collagen patch for orthopedic soft tissue injuries such as tendon repairs; and BriDGE Technology, a patented method to create a stabilized collagen matrix that supports tissue regeneration, accelerates wound healing, and prevents infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Harbor MedTech company profile →
RestoreFlow Logo

RestoreFlow

HQ: United States Website
  • Description: Provider of research into restorative transplantation of donated human tissue for medical treatment, operating in the healthcare industry; incorporated in 2013 and based in Chicago, Illinois.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RestoreFlow company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Humacyte

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Humacyte

2.2 - Growth funds investing in similar companies to Humacyte

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Humacyte

4.2 - Public trading comparable groups for Humacyte

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Humacyte

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Humacyte

What does Humacyte do?

Humacyte is a provider of bioengineered vascular and anatomical conduit solutions, including the Human Acellular Vessel (HAV) in clinical trials for trauma repair and arteriovenous access; the LUNA200 bioengineering system for producing HAV; and the BioVascular Pancreas in preclinical studies for type 1 diabetes, delivering insulin-producing islets.

Who are Humacyte's competitors?

Humacyte's competitors and similar companies include ACell, BioD Logics, Neuroplast, Harbor MedTech, and RestoreFlow.

Where is Humacyte headquartered?

Humacyte is headquartered in United States.

How many employees does Humacyte have?

Humacyte has 1,000 employees 🔒.

When was Humacyte founded?

Humacyte was founded in 2010 🔒.

What sector and industry vertical is Humacyte in?

Humacyte is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Humacyte

Who are the top strategic acquirers in Humacyte's sector and industry

Top strategic M&A buyers and acquirers in Humacyte's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Humacyte?

Top strategic M&A buyers groups and sectors for Humacyte include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Humacyte's sector and industry vertical

Which are the top PE firms investing in Humacyte's sector and industry vertical?

Top PE firms investing in Humacyte's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Humacyte's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Humacyte's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Humacyte's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Humacyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Humacyte's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Humacyte?

The key public trading comparables and valuation benchmarks for Humacyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Humacyte for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Humacyte with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Humacyte's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Humacyte with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Humacyte's' sector and industry vertical?

Access recent funding rounds and capital raises in Humacyte's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Humacyte